Early access to sickle cell and thalassaemia screening is important in giving time to women and couples to consider their options. Performance varies across the country, so we are sharing some best practice tips and a new checklist tool.
The sickle cell and thalassaemia screening support service provides advice on when antenatal screening results involving a raised level of Hb F, the fetal version of haemoglobin, should be followed up.
Key performance indicators (KPIs) measure how the NHS screening programmes are performing and aim to give a high level overview of programme quality. This blog article updates you on the latest KPI data publications. Quarter 2 and 3 KPI data …
Find out how the Sickle Cell Society's successful partnership work with the NHS Sickle Cell and Thalassaemia Screening Programme makes a difference to the lives of people who live with sickle cell disorders and their families.
Public Health England, NHS England and NHS Digital have begun an ongoing collaboration to move from printed invitation leaflets to online information, starting with antenatal and newborn screening.
Related content and links
The PHE Screening team
Public Health England (PHE) existed to protect and improve the nation’s health and wellbeing, and reduce health inequalities. It closed on 30 September 2021 and this blog is no longer updated.